Log in to save to my catalogue

Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway an...

Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway an...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6332796

Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery

About this item

Full title

Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery

Publisher

Australia: Ivyspring International Publisher

Journal title

Theranostics, 2019, Vol.9 (1), p.265-278

Language

English

Formats

Publication information

Publisher

Australia: Ivyspring International Publisher

More information

Scope and Contents

Contents

Epithelial-mesenchymal transition (EMT) is closely associated with the development of drug resistance. Lipid metabolism plays an important role in EMT. This work was to study the cholesterol-lowering drug simvastatin for reversing EMT-associated resistance to chemotherapy via lipid metabolism.
The combination of simvastatin and paclitaxel was us...

Alternative Titles

Full title

Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6332796

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6332796

Other Identifiers

ISSN

1838-7640

E-ISSN

1838-7640

DOI

10.7150/thno.27246

How to access this item